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Background and aim:We describe a series of three successive patients with perianal rhabdomyosarcoma (PRMS)
from 2014 to 2017 managed with combined chemotherapy, radical surgery, and radiotherapy.
Methods: Ethical consentwas obtained. Data including tumor presentation, treatment, and survival was collected
from hospital reports.
Results: Two girls aged 15 and 16 years (patient #1 and #2) and one boy aged ﬁve years (patient #3) were re-
ferred because of a suspected perianal abscess. MRI showed large perianal tumors from 7 to 12 cm in diameter
that surrounded or inﬁltrated the anal sphincters and were inconsistent with abscess. Tumor biopsies showed
RMS of alveolar (#1 and#2) and embryonal (#3) types. Patient #1had lymph node and bonemetastases, patient
#2 lymph node metastases, and patient #3 no metastases. Pretreatment staging, IRS Clinical Group, and Risk
Groups were: Stage 4, II, high; Stage 3, GII, intermediate; and Stage 3, I, low, respectively. All underwent colos-
tomy before neoadjuvant chemotherapy (CWS-RMS 2009 program). Neoadjuvant chemotherapy failed to
clear the tumors from anal sphincters preventing anus-saving surgery, and all patients underwent
abdominoperineal excision. All removed specimens had freemargins with negative lymph nodes. After adjuvant
chemotherapy and local radiation, the patients were tumor free after 48, 13, and 18 months.
Conclusion: In PRMS local surgical control required abdominoperineal excision. Confusion between PRMS and ab-
scess may cause unnecessary delay in management.
Level of Evidence: IV (Treatment Study, Case Series with no Comparison Group).
© 2018 Elsevier Inc. All rights reserved.Rhabdomyosarcoma (RMS) accounts for two-thirds of childhood
soft tissue sarcomas and 7–8% of all pediatric solid malignant tumors
[1]. Perineal or perianal location of RMS is rare and occurs in b2% of
the cases [2]. Outcome of patients with perianal or perineal RMS has
been regarded poor with combined survival only from 20–50% [3–5].
Treatment options have included chemotherapy, conservative or radical
excision of the tumor and local radiotherapy. In selected patients a com-
bination of brachytherapy in the treatment protocol may improve the
chances for non-mutilating surgery [6–9].
In this study we present a series of three successive patients with a
large perianal RMS (PRMS) that affected the levator ani and the anal
sphincter muscles. We describe the stage and histology of the tumors,
diagnostics, treatment, complications and survival.ection of Pediatric Surgery,
+358 504272412; fax: +358
.
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Consent from the local ethical board was obtained. PRMS was diag-
nosed in three successive patients in 2013 (n = 1) and 2016 (n = 2).
Patients #1 and #2were teenage girls aged 15 and 16 years and patient
#3 was a boy aged ﬁve years. All were previously healthy. Data was col-
lected from hospital records. All patients were initially referred by a
general practitioner with suspected perianal abscess.
2. Results
Initial MRI imaging showed main tumor mass from 7 to 12 cm of
diameter In all three patients. This was over the left buttock, in a
horse-shoe fashion round the anal canal and tumor inﬁltration between
levator ani and internal anal sphincter muscles. MRI showed enlarged
suspected metastatic lymph nodes in left inguinal and right para-iliac
locations and (#1) and in mesocolic fat and in left iliac bone (# 2).
Due to initial misdiagnosis of perianal abscess the biopsies occurred
from 11 to 31 days after the initial referral. Patient #3 underwent a
negative explorative incision. Histologic diagnosis was obtained by anbinedmanagement of perianal rhabdomyosarcomawith chemother-
y, https://doi.org/10.1016/j.jpedsurg.2018.10.090
Table 1
Clinical data and initial staging.
Patient Age Gender Histology Mutation N M Risk
group
Stage
1 15 Female Alveolar /
unfavorable
FOX 01
t(2;13)(q35;q14)
N1 M0 High III
2 16 Female Alveolar /
unfavorable
FOX 01
t(2;13)(q35;q14)
N1 M1 High IV
3 5 Male Embryonal /
favorable
N/A N0 M0 Low I
Fig. 2. Response to neoadjuvant chemotherapy in patient #3, preoperative MRI imaging.
Overall response is poor, the tumor has not diminished in size, partially prolapsed from the
perianal location and still attached to the levator ani muscles and external anal sphincters.
2 A.I. Koivusalo et al. / Journal of Pediatric Surgery xxx (xxxx) xxxopen tumor biopsy in #2 and #3 and from inguinal lymph node metas-
tasis in #1. Histopathology, staging and prognostic risk group class are
outlined in Table 1.
Due to the evident tumor inﬁltration into anal sphinctermuscles up-
front surgerywas not considered feasible in any of the three patients. All
patients underwent sigmoid colostomy before chemotherapy was initi-
ated because of pain, inﬂammation and ulceration and difﬁculties in
defecation caused by the tumors.
At the end of neoadjuvant chemotherapy MRI imaging indicated
moderate response in patient #1, whereas in #2 and #3 the radiologic
response was poor (Figs. 1 and 2). In all three patients inﬁltration of
the tumor into anal sphincters and levator ani muscles was unchanged.
Anus saving surgery was considered in all patients. Brachytherapy was
considered but abandoned because all three still had a substantial inﬁl-
trating residual tumor and because experience from brachytherapy in
PRMS in children was sparse [6,7]. The decision for abdominoperineal
excision and permanent colostomy was eventually made in agreement
with all three patients and their caregivers as it was felt that anus saving
surgery would carry also a high risk of tumor recurrence and anal
incontinence.
Operations included excision of the residual tumor with anus, and
total mesocolic excision of the rectosigmoid distal to the colostomy,
and pathological lymph nodes. In patients #1 and #2 the excision in-
cluded a narrow strip of the posterior vaginal wall.
Histopathology ﬁndings in the surgical specimens were as follows:
#1 – within the tumor mass an area of 2.5 cm in diameter with vital
RMS, free tumor margins, negative mesenteric and iliac lymph nodes;Fig. 1. Perianal rhabdomyosarcoma in patient #3. The tumor was RMS of embryonal type
and inﬁltrated the levator ani muscles and external anal sphincters.
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margins, negative mesenteric and iliac lymph nodes; #3 – a substantial
amount of vital RMS within the removed tumor mass, free tumor mar-
gins, negative mesenteric and iliac lymph nodes. In #3, the tumor re-
sponse to neoadjuvant chemotherapy was poor and this was
thereafter administered according to a high risk protocol (See Table 2).2.1. Postoperative course and complications
Patients #1 and #3 had primary wound healing. Patient #2 had de-
hiscence of the perineal incision which eventually healed after a gracilis
muscle ﬂapwas performed. This resulted in a 4-week delay in postoper-
ative chemotherapy and irradiation. Patients #2 and #3 needed to un-
dergo a laparotomy for small bowel obstruction. During the adjuvant
chemotherapy patient #1 suffered an episode of pulmonary thrombo-
embolism and both patients #1 and #3 developed vincristine-induced
neuropathy. All patients were referred to pediatric neuropsychological
surveillance and both girls were referred for gynecological surveillance.Table 2
Chemotherapy and irradiation.
Patient Age Neoadjuvant
chemo
Postoperative
maintenance
& irradiation
Adjuvant chemo
1 15 4 courses:
Carboplatin
Epirubisin
Vincristin
Local irradiation +
Oral
Trofosfamid
Etoposid
4 courses
Ifosfamide
Vincristin,
Etoposide
2 16 4 courses:
Carboplatin
Epirubisin
Vincristin
Local irradiation +
Oral
Trofosfamid
Etoposid
4 courses
Ifosfamide
Vincristin,
Etoposide
3 5 3 courses:
Ifosfamide
Vincristin
Actinomycin -d
Local irradiation 6 courses
Topotecan carboplatin (2)
carboplatin etoposide (2)
Cyclofosfamide vincristin
Doxorubicin (2)
binedmanagement of perianal rhabdomyosarcomawith chemother-
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After 48, 14 and 19months respectively of follow-up all patients have
no evidence of tumor recurrence. Patient 1 and 3 have returned to school
and resumed their former activities with mild psychological problems.
Patient 2 has psychological problems because of disﬁgured perineal re-
gion and colostomy which currently impedes her return to school.
3. Discussion
The present study described three patients with perianal rhabdo-
myosarcoma (PRMS) were treated by combined chemotherapy and ab-
lative surgery. As reported by Hill et al. in 2002, PRMS can be confused
with perianal abscess which can cause delay before the correct diagno-
sis is made [10]. In our patients the choice of the treatment included a
standard regimen of chemotherapy, surgery and irradiation. The choice
of surgery in all patients was abdominoperineal excision which
provided tumor free margins and harvest of mesenteric lymph nodes.
All patients remain tumor-free but the follow-up is too short to provide
5-year survival. Treatment of RMS aims primarily for survival but at
the same time mutilating surgery should preferably be avoided.
Abdominoperineal excision may be regarded as a maximally invasive
or near mutilating procedure and search for any anus-preserving
options can be considered justiﬁed. Local control of the disease is,
however, crucial for the successful management [11,12].
Fuchs et al. in 2014 reported 64% ﬁve-year survival in patients with
perineal (n= 8) or perianal (n= 24) rhabdomyosarcoma treated with
chemotherapy and conventional radiotherapy with or without mutilat-
ing surgery from 1986 to 2008. They concluded that tumor size b5 cm
diameter, age b10 years, low IRS group, negative locoregional lymph
nodes and embryonal histology were prognostically favorable factors.
A post-operative questionnaire for fecal continence identiﬁed
incontinence in 40% of responders [5].
A combination of conservative surgery and brachytherapy may pro-
vide better chances of organ saving surgery without compromising sur-
vival or recurrence [7]. Successful management of anal and distal rectal
cancer with brachytherapywith or without conservative surgery has al-
ready been reported [13]. In RMS of bladder /prostate and vulva/vagina
considerable results have been achieved of conservative surgery com-
bined with brachytherapy [14,15].
Conservative surgery with brachytherapy or with proton beam radi-
ation has also been used in perineal and PRMS but due to the rarity of
the disease the number of reported cases is low. Fuchs et al. (2016) [6]
reported two patients and Demoor-Goldschmidt et al. (2015) [7] one
patient with PRMS treated with combined surgery and brachytherapy.
The experience with the proton beam therapy is also limited to a few
patients [16,17]. A limitation of brachytherapy is its availability and
the risk of adverse effects on the intestine [9] and anal continence.
After conservative treatment of perineal or perianal RMS fecal
incontinence may be a signiﬁcant a problem. Fecal incontinence
may, however, be effectively treated by various methods including
ACE-appendicostomy [18].
Our decision to perform abdominoperineal excision was based on
the poor prognostic signs including of tumor site, tumor size, histology,
and, wewanted to ensure good local control. Not enoughwas known of
the efﬁciency of brachytherapy in PRMS encompassing the anus and the
sphincters. In a center with access to and experience of brachytherapy
and intraoperative proton beam radiation the choice of treatment
could, of course, have been different. Abdominoperineal excision causes
a signiﬁcant disﬁgurement and combined with radiotherapy consider-
able problems with skin irritation and pressure wounds beingPlease cite this article as: A.I. Koivusalo, R.J. Rintala andM.P. Pakarinen, Com
apy, radical surgery, and irradiation: A series..., Journal of Pediatric Surgerthe kind of morbidity that for a teenager is hard to accept.
Abdominoperineal excision may also detrimental to sexual function in
male and female alike [19,20]. When considered as the only surgical
means to provide local control of RMS as well as survival
abdominoperineal excision can be an acceptable choice which still
offers a moderately good quality of life to adult patients [20].CRediT authorship contribution statement
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